Projekte (Auszug Forschungs­datenbank)

Publikationen (Auszug Forschungs­datenbank)

Matz, K. (2020). TEE, too hard to swallow? European Journal of Neurology, 28/1: 1-2

Matz, K.; Tuomilehto, J.; Teuschl, Y.; Dachenhausen, A.; Brainin, M. (2020). Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke. Cardiovascular Diabetology, 19: https://doi.org/10.1186/s12933-020-01182-6

Matz, K.; Tuomilehto, J.; Teuschl, Y.; Dachenhausen, A.; Brainin, M. (2020). Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke. Cardiovascular Diabetology, 19(1): 204

Ntaios, G.; Michel, P.; Georgiopoulos, G.; et al. (2020). Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry. Stroke, 2020 Sep;51(9): e254-e258

Teuschl, Y.; Matz, K.; Dachenhausen, A.; Brainin, M. (2020). Impaired glucose metabolism and cognitive performance after mild stroke.

ASPIS Study Group (2018). Multidomain intervention for the prevention of cognitive decline after stroke - a pooled patient-level data analysis. Eur J Neurol., 25: 1182-1188

Brainin, M.; Feigin, V.; Martins, S.; Matz, K.; Roy, J.; Sandercock, P.; Teuschl, Y.; Tuomilehto, J.; Wiseman, A. (2018). Cut stroke in half: Polypill for primary prevention in stroke. Int J Stroke, 25: 633-647

Matz, K. (2018). Frühe Thrombolyse von Schlaganfällen. neurologisch, 03: 87

Teuschl, Y.; Trapl, M:, Ratajczak, P.; Matz, K.; Dachenhausen, A.; Brainin, M. (2018). Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. PLoS One, :e0192142: 10.1007/s00415-017-8720-8.

Mijajlovic, M.D.; Pavlovic, A.; Brainin, M.; Heiss, W.D.; Quinn, T.J.; Ihle-Hansen, H.B.; Hermann, D.M.; Assayag, E.B.; Richard, E.; Thiel, A.; Kliper, E.; Shin, Y.I.; Kim, Y.H.; Choi, S.; Jung, S.; Lee, Y.B.; Sinanovic, O.; Levine, D.A.; Schlesinger, I.; Mead, G.; Miloševic, V.; Leys, D.; Hagberg, G.; Ursin, M.H.; Teuschl, Y.; Prokopenko, S.; Mozheyko, E.; Bezdenezhnykh, A.; Matz, K.; et al. (2017). Post-stroke Dementia - a comprehensive review. BMC Medicine, 15(1):11: doi: 10.1186/s12916-017-0779-7

Teuschl, Y.; Matz, K.; Firlinger, B.; Dachenhausen, A.; Tuomilehto, J.; Brainin, M.; ASPIS Study Group. (2017). Preventive effects of multiple domain interventions on lifestyle and risk factor changes in stroke survivors: Evidence from a two-year randomized trial. International Journal of Stroke, 12(9): 976-984

Trapl, M.; Teuschl, Y.; Matz, K.; Dachenhausen, A.; Brainin, M. (2017). Overestimating the risk of aspiration in acute stroke. European Journal of Neurology, 24(6): doi:10.1111/ene.13298

Brainin, M.; Matz, K.; Nemec, M.; Teuschl, Y.; Dachenhausen, A.; Asenbaum-Nan, S.; Bancher, C.; Kepplinger B.; Oberndorfer, S.; Pinter, M.;, Schnider, P.; Tuomilehto, J.; ASPIS StudyGroup (2015). Prevention of poststroke cognitive decline: ASPIS - a multicenter,randomized, observer-blind, parallel group clinical trial to evaluate multiplelifestyle interventions - study design and baseline characteristics. International Journal of Stroke, 10(4): 627-35

Matz K.; Teuschl, Y.; Firlinger, B.; Dachenhausen, A.; Keindl, M.; Seyfang, L.; Tuomilehto, J.; Brainin, M. (2015). Multidomain Lifestyle Interventions for the Prevention of Cognitive Decline After Ischemic Stroke Randomized Trial. Stroke, 46(10): 2874-80

IST-3 collaborative group (2013). Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International StrokeTrial [IST-3]): 18-month follow-up of a randomised controlled trial. Lancet Neurol, 12(8): 768-76

Matz, K.; Brainin, M. (2013). Use of Intravenous recombinant tissue plasminogen activator in patients outside the defined criteria: safety and feasibility issues. Expert Rev Neurother, 13(2): 177-185

Teuschl, Y.; Brainin, M.; Matz, K.; Ferrari, J.; Lang, W. (2013). Time-trends in patient characteristics treated upon acute stroke units: Results from the Austrian Stroke Unit Registry 2003 – 2011. Stroke, 44(4): 1070-4

Teuschl, Y.; Matz, K.; Brainin, M. (2013). Prevention of post-stroke cognitive decline: a review focusing on lifestyle interventions. Eur J Neurol. 2013, 20(1): 35-49

IST-3 collaborative group (u.a. Brainin, M.), Sandercock, P.; Wardlaw, J.M.; Lindley, R.I.; Dennis, M.; Cohen, G.; Murray, G.; Innes, K.; Venables, G.; Czlonkowska, A.; Kobayashi, A.; Ricci, S.; Murray, V.; Berge, E.; Slot, K.B.; Hankey, G.J.; Correia, M.; Peeters, A.; Matz, K.; Lyrer, P.; Gubitz, G.; Phillips, S.J.; Arauz, A. (2012). The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet, 379(9834): 2352-63

Reiter, M.; Brainin, M.; Teuschl, Y.; Matz, K.; Seyfang, L.; Reindl, B. (2012). Thrombolysis in diabetic stroke patients: Results from the Austrian Stroke Unit Registry. Cerebrovasc Dis, 33 Suppl 2: 614-5

Mehr laden
von

Vorträge (Auszug Forschungs­datenbank)

Life Style oriented Interventions and Prevention of Vascular and Non-vascular Cognitive Decline

1st Krems Dementia Conference 2019, Krems, Österreich, 06.11.2019

Organizing Stroke Care

European Academy of Neurology Spring School 2019, 04.06.2019

Prognoseabschätzung beim hypoxischen Koma nach CPR

Fortbildung Landesklinikum Tulln, Austria, 20.11.2013

Therapie und Prophylaxe des ischämischen Schlaganfalls - Was gibt es Neues?

Kurie der niedergelassenen Neurologinnen und Neurologen , Tulln, Austria, 10.10.2013

Off Label Thrombolyse.

Fortbildung Landesklinikum Tulln, Austria, 30.03.2013

Häufige Fragestellungen an das elektroneurodiagnostische Labor – Standards

Fortbildung Landesklinikum Tulln, 13.01.2013

Time-trends in patient characteristics treate upon acute stroke units: Results from the Austrian Stroke Unit Registry 2003 and 2011

8th World Stroke Congress, Brasilia, Brazil, 11.10.2012

Thrombolysis in diabetic stroke patients: Results from the Austrian Stroke Unit Registry

XXI European Stroke Conference, Lissabon, Portugal, 27.05.2012

Diabetes und Thrombolyse

15. Jahrestagung der ÖGSF, Innsbruck, Austria, 27.01.2012

IST 3 - erste Auswertung der Baseline-Daten

15. Jahrestagung der ÖGSF, Innsbruck, Austria, 27.01.2012

IST 3 Trial - erste Zwischenergebnisse

15. Jahrestagung der ÖGSF, Innsbruck, Austria, 27.01.2012

Diabetestherapie an der Stroke Unit

15. Jahrestagung der ÖGSF, Innsbruck, Austria, 26.01.2012

10 Risk factors for post stroke pneunomia in patients treated in stroke units - Austrian Stroke Unit Registry

20th European Stroke Conference, Hamburg, Germany, 26.05.2011

Zum Anfang der Seite